Nifty
Sensex
:
:
23114.50
74532.96
112.35 (0.49%)
325.72 (0.44%)

Pharmaceuticals & Drugs

Rating :
52/99

BSE: 543748 | NSE: AARTIPHARM

644.60
20-Mar-2026
  • Open
  • High
  • Low
  • Previous Close
  •  649.85
  •  659.9
  •  637
  •  647.15
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  164744
  •  106329211.05
  •  971
  •  574.45

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 5,847.88
  • 27.36
  • 5
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 6,381.19
  • 0.78%
  • 2.80

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 43.10%
  • 2.73%
  • 34.85%
  • FII
  • DII
  • Others
  • 7.68%
  • 6.40%
  • 5.24%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 2.83

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 6.31

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 12.08

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 25.57

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 3.02

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 14.58

Earnings Forecasts:

(Updated: 21-03-2026)
Description
2024
2025
2026
2027
Adj EPS
30.06
26.13
32.75
35.2
P/E Ratio
21.44
24.67
19.68
18.31
Revenue
2086
2088.7
2496.9
2557.2
EBITDA
464.37
446.95
559.6
615.5
Net Income
272.4
233.8
290.6
303.5
ROA
9.93
P/B Ratio
2.94
2.85
2.55
2.27
ROE
14.54
11.05
12.3
12.4
FCFF
-87.8406
107.1
72.2
219.1
FCFF Yield
-1.3933
1.69878
1.14521
3.47529
Net Debt
356.909
BVPS
219.553
225.8
252.6
284.3

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Dec 25
Dec 24
Var%
Sep 25
Sep 24
Var%
Jun 25
Jun 24
Var%
Mar 25
Mar 24
Var%
Net Sales
432.27
537.78
-19.62%
418.34
458.03
-8.67%
386.19
555.49
-30.48%
563.78
505.77
11.47%
Expenses
329.97
409.17
-19.36%
343.62
364.35
-5.69%
290.95
459.03
-36.62%
418.15
388.25
7.70%
EBITDA
102.31
128.61
-20.45%
74.72
93.67
-20.23%
95.24
96.46
-1.26%
145.63
117.51
23.93%
EBIDTM
23.67%
23.91%
17.86%
20.45%
24.66%
17.36%
25.83%
23.23%
Other Income
-0.37
5.03
-
0.05
4.48
-98.88%
1.60
2.22
-27.93%
-1.61
2.03
-
Interest
12.58
9.97
26.18%
10.67
5.51
93.65%
6.80
4.83
40.79%
6.58
4.68
40.60%
Depreciation
28.62
23.04
24.22%
24.77
20.88
18.63%
22.79
20.17
12.99%
22.82
19.12
19.35%
PBT
57.94
100.63
-42.42%
39.34
71.77
-45.19%
67.25
73.68
-8.73%
114.62
95.75
19.71%
Tax
14.91
26.64
-44.03%
10.77
17.14
-37.16%
15.95
18.22
-12.46%
26.28
30.50
-13.84%
PAT
43.03
73.99
-41.84%
28.57
54.62
-47.69%
51.30
55.45
-7.48%
88.34
65.25
35.39%
PATM
9.95%
13.76%
6.83%
11.93%
13.28%
9.98%
15.67%
12.90%
EPS
5.29
8.16
-35.17%
3.08
6.03
-48.92%
5.46
6.12
-10.78%
9.75
7.20
35.42%

Annual Results

Standalone Figures in Rs. Crores /

Consolidated
Description
TTM
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Net Sales
1,800.58
2,115.07
1,852.61
1,945.23
1,199.94
0.00
Net Sales Growth
-12.47%
14.17%
-4.76%
62.11%
0
 
Cost Of Goods Sold
830.59
1,127.88
1,020.71
1,169.76
637.67
0.00
Gross Profit
969.99
987.20
831.89
775.48
562.27
0.00
GP Margin
53.87%
46.67%
44.90%
39.87%
46.86%
0
Total Expenditure
1,382.69
1,650.70
1,466.56
1,603.18
994.67
0.00
Power & Fuel Cost
-
81.32
84.03
75.10
90.00
0.00
% Of Sales
-
3.84%
4.54%
3.86%
7.50%
0
Employee Cost
-
148.65
128.03
121.32
85.20
0.00
% Of Sales
-
7.03%
6.91%
6.24%
7.10%
0
Manufacturing Exp.
-
141.94
105.52
98.78
145.95
0.00
% Of Sales
-
6.71%
5.70%
5.08%
12.16%
0
General & Admin Exp.
-
49.08
40.51
30.20
8.13
0.00
% Of Sales
-
2.32%
2.19%
1.55%
0.68%
0
Selling & Distn. Exp.
-
79.71
68.88
74.83
27.38
0.00
% Of Sales
-
3.77%
3.72%
3.85%
2.28%
0
Miscellaneous Exp.
-
22.12
18.88
33.20
0.34
0.00
% Of Sales
-
1.05%
1.02%
1.71%
0.03%
0
EBITDA
417.90
464.37
386.05
342.05
205.27
0.00
EBITDA Margin
23.21%
21.96%
20.84%
17.58%
17.11%
0
Other Income
-0.33
10.12
4.90
2.32
4.19
0.00
Interest
36.63
26.90
17.21
21.05
11.96
0.00
Depreciation
99.00
86.90
73.24
62.54
42.12
0.00
PBT
279.15
360.69
300.49
260.77
155.38
0.00
Tax
67.91
88.28
83.59
67.28
33.13
0.00
Tax Rate
24.33%
24.48%
27.82%
25.80%
21.32%
0.00%
PAT
211.24
272.40
216.90
193.49
122.25
0.00
PAT before Minority Interest
211.24
272.40
216.90
193.49
122.25
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
11.73%
12.88%
11.71%
9.95%
10.19%
0
PAT Growth
-15.27%
25.59%
12.10%
58.27%
0
 
EPS
23.32
30.07
23.94
21.36
13.49
0.00

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Shareholder's Funds
1,989.91
1,757.04
1,558.49
1,386.48
0.23
Share Capital
45.32
45.31
45.31
0.25
0.25
Total Reserves
1,942.86
1,711.50
1,513.17
1,340.91
-0.02
Non-Current Liabilities
259.45
130.68
84.91
72.76
0.00
Secured Loans
103.56
0.04
0.18
0.55
0.00
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
8.12
6.06
5.36
0.00
0.00
Current Liabilities
657.05
694.39
600.62
580.67
0.02
Trade Payables
277.83
378.32
339.50
214.59
0.00
Other Current Liabilities
73.54
45.84
38.33
11.89
0.00
Short Term Borrowings
292.80
263.92
213.78
337.73
0.02
Short Term Provisions
12.88
6.31
9.01
16.46
0.00
Total Liabilities
2,906.41
2,582.11
2,244.02
2,039.91
0.25
Net Block
1,136.57
1,033.33
925.84
782.09
0.00
Gross Block
1,795.66
1,609.29
1,431.25
1,225.00
0.00
Accumulated Depreciation
659.09
575.96
505.41
442.90
0.00
Non Current Assets
1,584.24
1,236.46
1,081.02
1,011.75
0.00
Capital Work in Progress
374.35
136.92
101.87
187.37
0.00
Non Current Investment
29.24
36.78
35.52
32.23
0.00
Long Term Loans & Adv.
44.08
29.44
17.78
10.07
0.00
Other Non Current Assets
0.00
0.00
0.00
0.00
0.00
Current Assets
1,322.17
1,345.64
1,163.01
1,028.15
0.25
Current Investments
47.56
70.39
50.99
0.00
0.00
Inventories
587.58
642.86
602.04
475.45
0.00
Sundry Debtors
575.40
519.34
450.10
376.66
0.00
Cash & Bank
8.65
24.07
12.19
83.27
0.25
Other Current Assets
102.98
17.01
7.70
10.74
0.00
Short Term Loans & Adv.
87.28
71.97
39.98
82.03
0.00
Net Current Assets
665.12
651.25
562.38
447.48
0.23
Total Assets
2,906.41
2,582.10
2,244.03
2,039.90
0.25

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 25
Mar 24
Mar 23
Mar 22
Cash From Operating Activity
331.56
216.35
250.12
-43.70
PBT
360.69
300.49
260.77
155.38
Adjustment
121.47
94.65
83.35
52.41
Changes in Working Capital
-86.07
-121.85
-31.63
-230.36
Cash after chg. in Working capital
396.09
273.29
312.50
-22.57
Interest Paid
0.00
0.00
0.00
0.00
Tax Paid
-64.53
-56.94
-62.38
-21.13
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
Cash From Investing Activity
-413.90
-214.56
-157.80
-138.74
Net Fixed Assets
-413.07
-203.41
-117.58
Net Investments
4.63
-6.18
-15.61
Others
-5.46
-4.97
-24.61
Cash from Financing Activity
65.44
9.72
-163.46
260.38
Net Cash Inflow / Outflow
-16.90
11.51
-71.15
77.94
Opening Cash & Equivalents
23.63
12.12
83.27
5.33
Closing Cash & Equivalent
6.73
23.63
12.12
83.27

Financial Ratios

Standalone /

Consolidated
Description
Mar 25
Mar 24
Mar 23
Mar 22
Book Value (Rs.)
219.36
193.85
171.97
53646.60
ROA
9.93%
8.99%
9.03%
11.98%
ROE
14.55%
13.08%
13.35%
18.23%
ROCE
17.59%
16.75%
16.11%
19.40%
Fixed Asset Turnover
1.24
1.22
1.46
0.98
Receivable days
94.46
95.50
77.57
114.57
Inventory Days
106.17
122.63
101.09
144.62
Payable days
106.17
128.34
86.45
61.41
Cash Conversion Cycle
94.46
89.79
92.21
197.78
Total Debt/Equity
0.20
0.15
0.14
0.25
Interest Cover
14.41
18.46
13.39
13.99

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.